MicroRNAs (miRNAs) are non-coding, single-stranded RNAs of ∼22 nt and constitute a novel class of gene regulators that are found in both plants and animals. Several studies have demonstrated that serum miRNAs could serve as potential biomarkers for the detection of various cancers and other diseases. A few documents regarding the stability of liver cancer-related miRNAs in serum are available. A systemic analysis of the stability of miRNA in serum is quite necessary. The purpose of this study was to evaluate the stability of miRNAs from three different sources, cultured liver cancer Huh-7 cell line, clinical liver cancer, and serum under different experimental conditions, including different temperature, time duration, pH values, RNase A digestion, DNase I digestion, and various freeze -thaw cycles. The qRT-PCR analysis demonstrated that liver cancer-related miRNAs were detectable under each of test conditions, indicating that miRNAs were extremely stable and resistant to destruction and degradation under harsh environmental conditions. However, ribosomal RNA was fragile and easily degraded by demonstrating sharp decrease of relative expression under the non-physiological test conditions. We also established a robust procedure for serum RNA extraction, which is greatly important not only for the miRNA profiling studies but also for the disease prognosis based on abnormal miRNA expression.
Introduction miRNAs are non-coding, single-stranded RNAs of 22 nt and constitute a novel class of gene regulators that are found in both plants and animals. They are likely involved in the regulation of diverse biological processes, such as growth, development, and metabolism through the regulated expression of 90% of all human genes [1] . Most miRNAs exert their regulatory effects by binding to imperfect complementary sites within the 3 0 untranslated regions (UTRs) of their mRNA targets, and the expression of target genes was apparently inhibited at posttranscriptional levels, through an RISC complex that is similar to, or possibly identical with, the one that is used for the RNAi pathway [2] .
Bioinformatic research indicated that one miRNA could even regulate hundreds of target genes. Recently, aberrant expression of miRNA has been reported in various cancers. miRNA mutation or aberrant expression is associated with various human cancers, suggesting that miRNAs can function as tumor suppressors and oncogenes [3] . The profiles of tissue miRNAs expression may be potentially useful in cancer characterization and classification [3] [4] [5] .
miRNAs are present not only in solid tumors, but also in the circulation and body fluids, e.g. urine, tear, ascetic fluid, and amniotic fluid [6] [7] [8] . miRNA expression is also tissue specific, tumor specific, and disease specific, therefore miRNAs are now being considered as a new class of circulating nucleic acids that serve as promising useful clinical biomarkers for diseases. Rabinowits et al. [9] found that the expression of specific circulating miRNAs was a good reflection of tumor miRNA expression, which might initiate a new paradigm that would be useful not only for early diagnosis, but also for prognostic and therapeutic decisions.
Analysis of miRNAs in the peripheral blood has been used for the early detection of cancer as well as the monitoring of cancer therapy. The first serum-miRNA biomarker discovered was miR-21 [10] . The expression of tumor-associated circulating miRNAs (miR-21, -155, and -210) in serum suggests that miRNAs can serve as potential non-invasive diagnostic markers for diffuse large B-cell lymphoma (DLBCL) [11] . Mitchell et al. [12] established a method to measure tumor-derived miRNAs in serum or plasma, and provided a new convenient approach for the detection of human prostate cancer. miRNAs originating from human prostate cancer xenografts entered the circulation, and could be detected in the plasma. They also showed that miRNAs were present in human plasma in a remarkably stable form that was protected from endogenous RNase degradation [12] . Taylor et al. [13] demonstrated that 8 miRNAs (miR-21, -141, -200a, -200b, -200c,  -203, -205 , and -214) present in the peripheral blood were also specific markers of ovarian cancer. miR-155 may be differentially expressed in the serum of women with hormone sensitive breast cancer compared with that of hormone insensitive breast cancer. Serum-miRNA screening is beneficial for the early detection and diagnosis of breast cancer [14] . Colorectal cancer, if detected at the early stage, is a highly curable disease [15] . miR-92 was significantly elevated in plasma of colorectal cancer patients and could be a potential non-invasive molecular marker for colorectal cancer screening [16] . Gastric cancer (GC) is the second leading cause of cancer-related death in the world. A research reported that miR-17-5p, miR-21, miR-106a, and miR-106b were significantly increased in GC patients than in controls, whereas let-7a was lower in GC patient plasma samples [17] . miR-500 could be a potential diagnostic marker for hepatocellular carcinoma according to Yamamoto et al. [18] . However, up to now, there are very few reports about liver cancer-specific miRNA biomarkers in serum.
As RNase is present in the blood of the healthy as well as cancer suffering individuals [19] , one would expect all circulating RNAs (including miRNAs) in the blood might be rapidly destroyed. However, accumulated data suggest that circulating RNAs may not be as fragile as previously assumed. Tsui et al. [20] found that RNAs in serum were more RNase resistant and more stable than previously thought. Circulating miRNAs were stable and could be reproducibly extracted and assayed in either serum or plasma [12] . In addition, miRNAs were likely far more stable than their protein counterparts during the long-term storage of biological samples [21] . The research by Chen et al. revealed that serum miRNAs were resistant to RNase A digestion, treatment with HCl ( pH ¼ 1) solution and NaOH ( pH ¼ 13) solution, and 10 cycles of freeze-thaw [7] . The serum miRNAs were stable even after drawing blood, which was very important for a reliable biomarker [7] . The stability of miRNAs in serum becomes the key issue of new biomarkers in serum. Therefore, a systemic analysis of miRNA stability and properties after different sample preparation procedures is needed.
The objectives of this study were to investigate: (i) the stability of the liver cancer-related miRNAs; (ii) the expression profiles of the liver cancer-related miRNAs; and (iii) the procedural analysis of high-quality RNA preparation. The overall objective of this study was to get a whole picture of miRNA stability under different conditions. For the methodology studies on circulating miRNAs, there were common technology platforms, such as miRNA microarray, northern blotting analysis [22] , qRT-PCR analysis [23] , deep sequencing approaches [7] , and so on. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) has high sensitivity and specificity, therefore it was used in our experiment.
Materials and Methods
Sample collection Cultured liver cancer Huh-7 cell-line was donated by Professor Cheng Qian, Xinyuan Institute of Medicine and Biotechnology, Zhejiang Sci-Tech University (Hangzhou, China). Clinical samples of liver cancer tissues were obtained from Zhejiang Cancer Hospital (Hangzhou, China) with appropriate ethical approval. Clinical serum samples were obtained from Zhejiang Dongfang Hospital (Hangzhou, China) with appropriate ethical approval. All these clinical samples were taken freshly and kept at 2808C until use.
Total RNA isolation and treatment Total RNA was extracted from Huh-7 cells using Trizol reagent (Invitrogen, Carlsbad, USA) according to the manufacturer's instructions. This method is highly reproducible and remains a 'gold standard' for RNA isolation [24] .
The frozen tumors were sectioned into small pieces (about 25 mg) on a cryostat under aseptic conditions prior to homogenization in lysis solution provided in the Norgen's animal tissue RNA purification kit (Norgen Biotek Corporation, Thorold, Canada). Total RNAs were extracted from the homogenized tissue samples by using the Norgen's animal tissue RNA purification kit according to the manufacturer's instructions.
Serum miRNAs were extracted with Trizol reagents according to the manufacturer's protocol with a modification for robust efficiency of extraction. Each serum sample (250 ml) was added to a 1.5-ml RNase-free Eppendorf tube, heated at 758C for 5 min and incubated at 428C for 60 min. Then same volume of Trizol reagents was added, mixed, and kept at room temperature for 5 min. Chloroform (100 ml) was added, vortexed for 15 s, and then kept for 2 min. The Eppendorf tube was centrifuged (12,000 g) at 48C for 15 min. The supernatant was carefully transferred to a new tube, mixed with 2 volume of isopropyl alcohol, and allowed to stand at room temperature for 10 min and centrifuged (12,000 g) at 48C for 15 min. The supernatant was discarded. The purified serum RNAs in the pellet were air dried, and dissolved in water. The serum RNA isolation efficiency was evaluated by using qRT-PCR.
The RNA concentration and purity of all samples were measured by the NanoDropwND-1000 (ND-1000 Spectrophotometer V3.5; NanoDrop Technologies, Wilmington, USA). RNA integrity was examined by using denaturing agarose gel electrophoresis.
Several different treatments were conducted on serum, total RNA from Huh-7 cells and tumor tissues: (i) 3 h of incubation under different temperatures (2808C, 2208C, 48C, room temperature, and 378C); (ii) incubation at room temperature for different time (0, 1, 3, 6, 12, and 24 h); (iii) RNase A digestion at 378C for different time (0, 3, 6, and 12 h); (iv) DNase I digestion at 378C for different time (0, 3, 6, and 12 h); (v) different freeze-thaw cycles (0, 2, 5, 7, and 10 cycles); and (vi) 3 h of incubation at 378C under different pH values ( pH 1, pH 6, pH 7, pH 9, and pH 13) prior to RT reaction.
Stem-loop RT-PCR assay
Stem-loop RT-PCR assay was used to assess the stability of seven liver cancer-related miRNAs, miR-21 [25, 26] , miR-25 [27] , miR-29c [28, 29] , miR-93 [22, 28, 30, 31] , miR-198 [29] , miR-221 [22, 32] , and miR-222 [28, 33] . The 18S rRNA was used as a reference. Mature miRNAspecific primers including stem-loop primers were designed by Primer 5.0 and evaluated by DNAStar 6.0 software (DNASTAR, Inc., Madison, USA) ( Table 1) , based on sequences obtained from the miRBase sequence database (Release 14: September 2009; http://www.mirbase.org).
RT reaction solution (5 ml) contained 5 Â RT buffer, 10 mM of each dNTP (TaKaRa, Dalian, China), 200 U/ml of M-MLV reverse transcriptase (TaKaRa), 40 U/ml of RNase inhibitor (TaKaRa) and 0.25 ml of stem-loop/reverse primer. Total RNA (100 ng) from Huh-7 cells or liver tissues, or 40 ng total RNA from serum was used for each test. The mixtures were incubated at 168C for 15 min, 428C for 60 min, and 858C for 5 min. All RT reactions, including no-template (no cDNA) controls and minus controls (no reverse transcriptase), were run in a GeneAmp PCR 9700 Thermocycle (Applied Biosystems, Foster City, USA).
PCR reaction mixtures (10 ml) included 0.2 ml of RT products (1:10 dilution), 10 Â PCR buffer, 2.5 mM of each dNTP, 5 U/ml of Taq (TaKaRa), and 10 mM of forward primer and 10 mM of reverse primer. The mixtures were pre-incubated at 958C for 3 min, followed by 35 cycles of 958C for 15 s, 608C for 30 s and 728C for 1 min, and then incubated at 728C for 10 min. PCR products were visualized on ethidium bromide-stained 12% DNA polyacrylamide gel.
The qPCR reaction was performed on an Applied Biosystems 7300 Sequence Detection system. PCR reaction mixtures (10 ml) contained 1 ml of RT products, 5 ml of Thunderbird SYBRw qPCR Mix, 0.2 ml of 50 Â ROX reference, and 0.2 ml of each PCR primers. The mixtures were incubated at 958C for 1 min, followed by 40 cycles of 958C for 15 s and 608C for 1 min. All reactions were run in triplicate, including no-template controls and minus controls.
The level of miRNA expression was measured by using Ct (threshold cycle) value. The Ct value was determined for each gene and the relative amount of each miRNA compared with 18S rRNA was described by using the equation 2 -DCt , where DCt ¼ (Ct miRNA 2 Ct 18S rRNA ) [34] . Then, Pearson correlation coefficient was analyzed by using SPSS software.
Statistical analysis
All results from qRT-PCR were representative of at least three replications. Assays that had Ct value .35 were removed from the analysis. The P value ,0.05 was considered statistically significant with Student's t-test.
Pearson's correlation coefficient is a measurement of the strength of the linear relationship between two variables. It is usually signified by R (rho), and can take on the values from 21.0 to 1.0. R is defined by scatter plot and tested by using t-test for statistical significance.
Results
RNA integrity of liver cancer cell line and cancer tissue samples RNA integrity of cell line and tissue samples was examined by using denaturing agarose gel electrophoresis ( Supplementary Fig. S1 ). The OD value of total RNA was shown in Supplementary Table 1 . The results showed that the quality of total RNA is up to the general standard.
Efficiency of serum RNA isolation
The results indicated that pre-heating treatment of the samples greatly increased the extraction efficiency of serum RNA (Fig. 1) . The Ct value decreased at least 5 after heat treatment. In conclusion, our study provided an optimized procedure for serum RNA isolation.
The expression levels of specific miRNAs
The expression levels of a specific group of miRNAs were evaluated by semi-quantitative RT-PCR analysis with 30 cycles. PCR products were visualized on ethidium bromidestained 12% DNA polyacrylamide gel ( Supplementary  Fig. 2 ). Eight genes were present in the liver cancer cell line, clinical caner tissues, and serum. They could also be amplified well.
Comparison of miRNA expression before and after treatment We randomly chose three miRNAs from liver cancer tissue and serum samples for analysis. The stability of serum miRNAs was further studied by using serum/total RNA from various sources, after harsh treatments including (Figs. 2-4) . Moreover, serum miRNAs remained stable when serum/total RNA were treated at 378C for 12 h, under pH 1, 6, 9, and 13 [ Figs. 2-4(F) ].
The Ct values of each miRNA in serum were illustrated in Fig. 5(A) . We evaluated the Pearson's correlation coefficient of liver cancer-related miRNAs expression in 22 healthy human subjects (11 males and 11 females) by SL-P, stem-loop primer; F-P, forward primer; R-P, reverse primer.
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qRT-PCR. Expression levels of serum miRNAs were reproducible and consistent among 22 healthy human subjects for the R value was significant with P , 0.05 [ Fig. 5(B) ]. R 2 in Pearson correlation scatter plot of the relative serum-miRNAs expression between male and female samples was 0.0953 [ Fig. 5(C) ], indicating that miRNA expression was not correlated with gender. Taken together, these results showed that miRNAs in serum were stable and that their expression levels were consistently reproducible among individuals of the same species.
Discussion
Serum contains abundant ribonuclease, but miRNAs are highly resistant to the enzymatic cleavage by serum RNase A and DNase I (Figs. 2-4) . In contrast, RNAs with highmolecular weight were rapidly degraded by RNase A. This is probably because the free miRNAs in the serum were wrapped up by proteins, or stored within the vesicles for their specific stability [35] [36] [37] . Peripheral blood circulating (pH 1, 6, 7, 9 , and 13) of solution treated for 3 h of incubation at 378C. CK, pH ¼ 7.
Stability analysis of liver cancer-related microRNAs miRNAs were likely to spontaneously combined with nucleoprotein [38] , lipids [39] , proteolipid [40] , glycoprotein [41] , and p53 [42] to form complexes, or coated in apoptotic bodies [43, 44] , and syncytiotrophoblast microparticles [45] , while most of the RNA monomer were degraded [46] . Halicka et al. [47] confirmed that there were apoptotic bodies in vivo. RNA and DNA were packaged into separate apoptotic bodies and the compounds were transported into blood during the apoptosis of tumor cells in cancer patients. Furthermore, miRNAs are short ( 22 nt) and have no complex secondary structure while regular mRNAs have. Our results showed that miRNAs were very stable regardless of the sources from serum, cultured cancer cell line, or cancer tissue.
Previous reports about miRNA stability have mostly focused on certain conditions. For example, Mraz et al. [24] assessed miRNA stability in stored RNA samples, and found that a freshly isolated RNA sample could be stored over a period of 10 months at 2808C. Stored RNA sample over shorter time periods at 48C (up to 96 h) and no significant differences were noticed in the three diagnostic miRNAs analyzed [13] . RNA samples were stable for reasonable periods of time. They can be stored at room temperature and freeze-thaw several cycles before routine processing of clinical samples [8] . Chim et al. [48] focused on the room temperature condition. Although Chen et al. [7] used several different treatments including freezethaw cycles, strong acidic-alkaline solution, and DNase I digestion, miRNA stability was only examined in serum samples. In the experiment with different pH solutions, only strong acid or alkaline solution was used. The weak acid and alkaline solution were widely used in the RT reaction and they were not studied before. Our study tried to examine all potential factors on miRNA stability. We used 
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RNAs from different sources (liver cancer cell line, liver cancer tissues, and serum) in our experiment.
Several studies implied that miRNAs were aberrantly expressed in primary liver tumors, serving both as putative tumor suppressors and as oncogenic regulators [29] . miRNA signatures might have significance in classification, diagnosis, and outcome prediction in cancer patients [49] [50] [51] [52] . A couple of serum-based biomarkers have been used for diagnosis of certain diseases for several decades. Examples are AFP (alpha-fetoprotein) for liver cancer and CRP (C-reactive protein) for inflammation and diabetes [7] . Single blood-based biomarker has limitations in clinical use for lacking of sufficient sensitivity, specificity, and accuracy. However, circulating miRNA signatures of tumor-derived exosomes may have very high sensitivity and specificity. miR-21 and miR-155 were specific for early diagnosis of non-small-cell lung cancer [53] . Zhu et al [14] and Taylor et al [13] indicated that a subset of miRNAs may be useful diagnostic biomarkers for breast cancer. miR-21 has the potential as a diagnostic biomarker for DLBCL [11] . Serum-miR-141 levels could distinguish prostate cancer patients [12] from normal. These studies suggested that a subset of biomarkers could be a better diagnostic tool for specific tumors with much higher sensitivity, specificity, and accuracy. It is likely that a subset of specific serum miRNAs (miR-21, -25, -29c, -93, -198, -221, and -222) are potential new biomarkers of liver cancer.
The serum contains large amounts of stable miRNAs derived from various tissues/organs. We also clearly showed that the serum miRNAs are stable, reproducible, and consistent among individuals of the same species. Their expression profiles could be used as a novel serum-based potential Our results suggested that it was advantageous and rational to use stable miRNAs as blood-based cancer biomarkers. The measurement of the expression of serumderived miRNAs can serve as clinical detection at early stage with a few characteristics of sensitivity, specificity, and facility.
In addition, we found that pre-heating treatment of the serum samples greatly increased the extraction efficacy of serum RNA. There were many microparticles and exosomes in serum. And miRNAs in serum were incorporated in microparticles and exosomes [15] . After pre-heating treatment of serum, the miRNAs dissociate from microparticles and exosomes. So the serum RNA isolation procedure was improved. Our study provides an optimized procedure for serum RNA isolation, which is of great importance not only for the miRNA profiling studies but also for the disease prognosis based on of abnormal miRNA expression. 
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